Blog Posts in July, 2010

  • ACLU Claims Illinois Nursing Homes Use Scare Tactics to Keep Patients

    The State of Illinois recently reached a court settlement that offers supportive community-based housing and treatment to about 4,500 psychiatric patients who currently reside in nursing homes. Following this settlement, the Chicago Tribune reported that the American Civil Liberties Union (ACLU) filed court papers stating that Illinois for-profit nursing home operators were using scare tactics to ...
    Continue Reading
  • FDA Panelist Defending Avandia was on its Manufacturer’s Payroll

    It was recently reported by the Wall Street Journal that one of the members of the government advisory panel who voted to back Avandia last week was on GlaxoSmithKline'€™s payroll. More specifically, endocrinologist David Capuzzi is a paid speaker for the drug manufacturer. Avandia, a diabetes drug, has carried the Federal Food and Drug Administration’s (€œFDA'€™s€) strongest warning, a black ...
    Continue Reading
  • New Report Says Over-the-Counter Nasal Gels are Ineffective and May Cause Loss of Smell

    Popular over-the-counter nasal gels may cause loss of smell or anosmia. Over-the-counter nasal gels, such as Zicam, are generally used to treat common cold symptoms. Patients use this product by wiping the gel inside the nasal passages. Doctors state it is likely the nasals gels cause loss of smell because they contain zinc gluconate. They also express doubt that the products are actually ...
    Continue Reading
  • GlaxoSmithKline Hid Relevant Data on Avandia’s Risk for Cardiovascular Problems

    As a follow-up to our previous blog on the current controversy surrounding the popular diabetes drug Avandia, it was recently reported that Avandia's manufacturer GlaxoSmithCline hid a 1999 study that indicated the drug's danger. In the fall of 1999, the manufacturer secretly began a study to test if Avandia was better and safer in terms of heart problem risks than the competing drug Actos. The ...
    Continue Reading
  • FDA Withdraws Cancer Drug Due to Lack of Benefit and Increased Deaths

    Recently, Pfizer Inc voluntarily withdrew the drug Mylotarg (gemtuzumab ozogamicin) from the U.S. market. Mylotarg is used to treat patients with acute myeloid leukemia, a bone marrow cancer. Pfizer withdrew the drug at the request of the Federal Food and Drug Administration (FDA) since a new clinical trial yielded both new safety concerns and lack of benefit to patients. Mylotarg was approved by ...
    Continue Reading
  • Experts Debate if Avandia Clinical Trial is Ethical

    Over the past couple of years, the safety of the popular diabetes drug Avandia has been the source of much debate, due to claims that it increases the risk of heart attack. Recently, it was reported that a clinical trial conducted by Avandia is being increasingly scrutinized by experts. Some specialists and FDA officials stated that Avandia is too dangerous to stay on the market due to its risks. ...
    Continue Reading
  • Illinois Nursing Home Gets License Revoked

    Recently, the Chicago Tribune reported that Illinois health authorities have moved to revoke the license of Evergreen Health Care Center in Evergreen Park, a southwest suburban nursing home. Evergreen Health Care is partly owned by state Senator Heather Steans, a prominent advocate of reform legislation to improve safety and care standards in Illinois nursing homes. The revocation of its license ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.